Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Protein, malnutrition and wasting disorders

Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial

European Journal of Clinical Nutrition volume 73, pages 293–301 (2019)Cite this article

Subjects

ABSTRACT

Background

Carnitine deficiency is common in patients on hemodialysis. However, the efficacy of L-carnitine supplementation for improving lean body mass (LBM) and physical function has not yet been evaluated.

Methods

In this multicenter, prospective, parallel, randomized, controlled trial, 91 patients on hemodialysis who developed carnitine deficiency were randomly assigned to receive injections of 1,000 mg L-carnitine 3 times per week after each hemodialysis session (L-carnitine group) or no injections (control group) with monitoring for 12 months.

Results

The data for 84 of the 91 patients were available for analysis (L-carnitine group, n = 42; control group, n = 42). Dry weight and body mass index did not significantly change in the l-carnitine group, but significantly decreased in the control group. Arm muscle area (AMA) did not change significantly in the L-carnitine group but decreased significantly in the control group; the difference in mean AMA between the groups was 6.22% (95% confidence interval [CI] 1.90–10.5; P = 0.037). Hand grip strength did not change significantly in the L-carnitine group, but decreased significantly in the control group. The difference in change in hand grip strength between the groups was 4.27% (95% CI 0.42–8.12; P = 0.030). Furthermore, LBM did not change significantly in the l-carnitine group but decreased significantly in the control group; the difference in mean LBM between the groups was 2.92 % (95% CI 1.28–4.61; P = 0.0007).

Conclusions

l-carnitine supplementation is useful in patients who develop carnitine deficiency on hemodialysis because it maintains physical function and LBM.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Evans AM, Faull RJ, Nation RL, Prasad S, Elias T, Reuter SE, et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int. 2004;66:1527–34.

    Article  CAS  Google Scholar 

  2. Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S, et al. Levocarnitine improves cardiac function in hemodialysis patients with left ventricular hypertrophy: a randomized controlled trial. Am J Kidney Dis. 2016;67:260–70.

    Article  CAS  Google Scholar 

  3. Schreiber B. Levocarnitine and dialysis: a review. Nutr Clin Pract. 2005;20:218–43.

    Article  Google Scholar 

  4. Matera M, Bellinghieri G, Costantino G, Santoro D, Calvani M, Savica V. History of L-carnitine: implications for renal disease. J Ren Nutr. 2003;13:2–14.

    Article  Google Scholar 

  5. Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13:1–7.

    Article  Google Scholar 

  6. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29:154–9.

    Article  CAS  Google Scholar 

  7. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc. 2011;12:249–56.

    Article  Google Scholar 

  8. Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, et al. International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84:1096–107.

    Article  CAS  Google Scholar 

  9. Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24:337–51.

    Article  Google Scholar 

  10. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23:77–90.

    Article  Google Scholar 

  11. Johansen KL, Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int. 2000;57:2564–70.

    Article  CAS  Google Scholar 

  12. Stack AG, Martin DR. Association of patient autonomy with increased transplantation and survival among new dialysis patients in the United States. Am J Kidney Dis. 2005;45:730–42.

    Article  Google Scholar 

  13. Bishop CW. Reference values for arm muscle area, arm fat area, subscapular skinfold thickness, and sum of skinfold thicknesses for American adults. J Parenter Enter Nutr. 1984;8:515–22.

    Article  CAS  Google Scholar 

  14. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101.

    Article  Google Scholar 

  15. Badrasawi M, Shahar S, Zahara AM, Nor Fadilah R, Singh DK. Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial. Clin Interv Aging. 2016;11:1675–86.

    Article  CAS  Google Scholar 

  16. Evans M, Guthrie N, Pezzullo J, Sanli T, Fielding RA, Bellamine A. Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study. Nutr Metab (Lond). 2017;14:7.

    Article  Google Scholar 

  17. Malaguarnera M, Cammalleri L, Gargante MP, Vacante M, Colonna V, Motta M. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr. 2007;86:1738–44.

    Article  CAS  Google Scholar 

  18. Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, et al. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Arch Gerontol Geriatr. 2008;46:181–90.

    Article  CAS  Google Scholar 

  19. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003;41(Suppl 4):S4–12.

    Article  CAS  Google Scholar 

  20. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251–63.

    Article  CAS  Google Scholar 

  21. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.

    Article  CAS  Google Scholar 

  22. Abe M, Kalantar-Zadeh K. Haemodialysis-induced hypoglycaemia and glycaemic disarrays. Nat Rev Nephrol. 2015;11:302–13.

    Article  CAS  Google Scholar 

  23. Johansen KL. The frail dialysis population: a growing burden for the dialysis community. Blood Purif. 2015;40:288–92.

    Article  Google Scholar 

  24. Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18:2960–7.

    Article  Google Scholar 

  25. Bellinghieri G, Santoro D, Calvani M, Savica V. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients. J Ren Nutr. 2005;15:13–7.

    Article  Google Scholar 

  26. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136–48.

    Article  CAS  Google Scholar 

  27. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationship between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953–60.

    Article  CAS  Google Scholar 

  28. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004;80:299–307.

    Article  CAS  Google Scholar 

  29. Bistrian BR, Schwartz J, Istfan NW. Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc Soc Exp Biol Med. 1992;200:220–3.

    Article  CAS  Google Scholar 

  30. Duranay M, Akay H, Yilmaz FM, Senes M, Tekeli N, Yücel D. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients. Nephrol Dial Transplant. 2006;21:3211–4.

    Article  CAS  Google Scholar 

  31. Suchitra MM, Ashalatha VL, Sailaja E, Rao AM, Reddy VS, Bitla AR, et al. The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients. Saudi J Kidney Dis Transpl. 2011;22:1155–9.

    CAS  PubMed  Google Scholar 

  32. Shakeri A, Tabibi H, Hedayati M. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. Hemodial Int. 2010;14:498–504.

    Article  Google Scholar 

  33. Siew ED, Ikizler TA. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Semin Dial. 2010;23:378–82.

    Article  Google Scholar 

  34. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia. 1995;38:565–72.

    Article  CAS  Google Scholar 

  35. Mak RHK. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol. 1996;270:F839–94.

    CAS  PubMed  Google Scholar 

  36. Abe M, Okada K, Soma M, Matsumoto K. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients. Clin Nephrol. 2011;75:49–58.

    CAS  PubMed  Google Scholar 

  37. Rasmussen BB, Holmbäck UC, Volpi E, Morio-Liondore B, Paddon-Jones D, Wolfe RR. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest. 2002;110:1687–93.

    Article  CAS  Google Scholar 

  38. Günal AI, Celiker H, Dönder E, Günal SY. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure. J Nephrol. 1999;12:38–40.

    PubMed  Google Scholar 

  39. Savica V, Calvani M, Benatti P, Santoro D, Monardo P, Peluso G, et al. Carnitine system in uremic patients: molecular and clinical aspects. Semin Nephrol. 2004;24:464–8.

    Article  CAS  Google Scholar 

  40. Schreiber B. Levocarnitine and dialysis: a review. Nutr Clin Pract. 2005;20:218–43.

    Article  Google Scholar 

  41. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol. 1988;255:E946–952.

    CAS  PubMed  Google Scholar 

  42. Capaldo B, Napoli R, Di Bonito P, Albano G, Saccà L. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract. 1991;14:191–5.

    Article  CAS  Google Scholar 

Download references

Author contributions

Research concept and study design: TH, TM, NM. Acquisition of data: CN, HT, MK, KU, RT, TF, TY, EO. Data analysis and interpretation: TM, NM. Statistical analysis: TH, MA. Supervision or mentorship: HA, FK. Each author contributed significant intellectual content during drafting or revision of the manuscript and takes accountability for the overall work by ensuring appropriate investigation and resolution of questions pertaining to the accuracy or integrity of any aspect of this work.

Author information

Author notes

    Authors and Affiliations

    1. Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

      Takashi Maruyama, Noriaki Maruyama, Chinami Nagura, Hiroyuki Takashima, Maki Kitai, Kei Utsunomiya, Ritsukou Tei, Tetsuya Furukawa & Masanori Abe

    2. Department of Nephrology, Keiai Hospital, Tokyo, Japan

      Terumi Higuchi, Toshio Yamazaki & Erina Okawa

    3. Department of Cardiology, Keiai Hospital, Tokyo, Japan

      Hideyuki Ando

    4. Department of Nephrology, Meirikai Chuo General Hospital, Tokyo, Japan

      Fumito Kikuchi

    Authors
    1. Takashi Maruyama
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Noriaki Maruyama
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Terumi Higuchi
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Chinami Nagura
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Hiroyuki Takashima
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Maki Kitai
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Kei Utsunomiya
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Ritsukou Tei
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Tetsuya Furukawa
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Toshio Yamazaki
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Erina Okawa
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Hideyuki Ando
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Fumito Kikuchi
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Masanori Abe
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Masanori Abe.

    Ethics declarations

    Conflict of interest

    MA has received honoraria from Otsuka Pharmaceutical Co., Ltd. The other authors declare that they have no conflict of interest.

    Additional information

    These authors contributed equally: Takashi Maruyama, Noriaki Maruyama

    Electronic supplementary material

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Maruyama, T., Maruyama, N., Higuchi, T. et al. Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial. Eur J Clin Nutr 73, 293–301 (2019). https://doi.org/10.1038/s41430-018-0348-y

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1038/s41430-018-0348-y

    This article is cited by

    Search

    Advanced search

    Quick links